InvestorsHub Logo
Followers 2
Posts 236
Boards Moderated 0
Alias Born 10/17/2015

Re: None

Thursday, 01/05/2017 9:36:54 AM

Thursday, January 05, 2017 9:36:54 AM

Post# of 5001
Jan 5 (Reuters) - Orexigen Therapeutics Inc :

* Anticipates filing of new drug submission for contrave with Health Canada by partner, Valeant Canada in Q1 2017

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BHC News